Med-X Withdraws IPO Plan; Elects Not To Pursue Sale Of Securities At This Time - Filing
https://www.sec.gov/Archives/edgar/data/1620704/000147793224002292/medx_rw.htm
Med-X Withdraws IPO Filing
Med-X Withdraws IPO Filing
Med-X Secures High-Priority Order to Address Bed Bug Issue Impacting the Republic of Singapore
Med-X Fulfills Bulk Order to Address Urgent Bed Bug Issue Impacting SingaporeAll-Natural Nature-Cide Products Provide a Safe Alternative to Control Pests in Sensitive Areas such as Homes and HotelsLOS
Med-X Announces International Expansion of Nature-Cide Product Distribution With Global Pest Control Leader Ensystex
Med-X Builds Upon Early Successes of U.S. Distribution Agreement with Ensystex, Fortifying Nature-Cide's Global Sales Footprint in 29 Territories Across Asia, Oceana, Southern Africa and the Middle Ea
Med-X Acquires 49% Interest in NAPCO Painting Contractors
Med-X Makes Strategic Minority Investment in a Napa Valley Based Green Scene Painting CompanyManagement Exploring Nature-Cide Insecticidal Paint Additive Alongside NAPCO TeamLOS ANGELES, CA / ACCESSWI
Med-X Expects to Offer 1.15M Shrs in IPO at Price of $4 to $6 Each, Previously Expected to Offer 2.125M Shares With Assumed Price of $4 Each
Med-X Expects to Offer 1.15M Shrs in IPO at Price of $4 to $6 Each, Previously Expected to Offer 2.125M Shares With Assumed Price of $4 Each
A Look At Upcoming IPOs For The Week
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are s
MED-X, INC Announces 2.125M Share IPO at $4/sh
MED-X, INC (MXRX) has filed for 2,125,000 share IPO at $4 per share.
Med-X Announces New Registrations of Flagship Nature-Cide Product Line in Caribbean Islands
Registration of Nature-Cide Across the Caribbean Enhances Global Presence while Enabling Caribbean Sustainability GoalsLOS ANGELES, CA / ACCESSWIRE / May 31, 2023 / Med-X, Inc., a leading innovator of
Med-X to Attend 13th Annual LD Micro Invitational
CEO Matthew Mills to Host One-on-One Meetings with Institutional Investors at Preeminent Investor Conference for Small-Cap Public CompaniesLOS ANGELES, CA / ACCESSWIRE / May 24, 2023 / Med-X, Inc., a
Med-X to Present at Planet MicroCap Showcase From April 26-27, 2023
Management to Build Relationships with Institutional Investors at Leading Investor Conference for Small-Cap Public CompaniesLOS ANGELES, CA / ACCESSWIRE / April 19, 2023 / Med-X, Inc., a leading innov
Med-X to Showcase Nature-Cide Product Portfolio at the Veseris Global Sales Meeting on February 21, 2023
LOS ANGELES, CA / ACCESSWIRE / February 20, 2023 / Med-X, Inc., a leading innovator of all-natural green scene bio-solutions addressing the pest control, health and wellness markets, today announced t
Med-X Looking to Make a Difference in the World With Green Solution to Everyday Problems
Med-X CEO Matthew Mills joined Steve Darling from Proactive to share news about the company that look to put a green spin on products that are used everyday in a number of industries.
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo From January 11-12, 2023
Med-X to Showcase Nature-Cide Product Portfolio at the Target Specialty Products National Meeting and Expo from January 11-12, 2023LOS ANGELES, CA / ACCESSWIRE / January 9, 2023 / Med-X, Inc., a leadi
Med-X Announces Distribution Agreement With Ensystex for Nature-Cide Portfolio of Products
Leading Supplier to Pest Management Professionals to Further Enhance Nature-Cide's Growing Global Distribution NetworkLOS ANGELES, CA / ACCESSWIRE / November 14, 2022 / Med-X, Inc., a leading innovato
MED-X, INC. Plans $8 Million IPO for November 2nd (MXRX)
MED-X, INC. (MXRX) plans to raise $8 million in an IPO on Wednesday, November 2nd, IPO Scoop reports. The company will issue 2,100,000 shares at a price of $4.00 per share. In the last year, MED-X, I
Med-X Inc. Revises Planned IPO to 2.13 Million Shares at $4 Each
By Colin Kellaher Med-X Inc. on Wednesday revised the terms of its initial public offering, raising the number of shares it plans to sell but trimming the expected price. The Canoga Park, Calif., su
Med-X to Attend PestWorld Conference in Boston From October 11-14, 2022
LOS ANGELES, CA / ACCESSWIRE / October 10, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend PestWorld Boston 2022 - a leading event in the pest control industry - taking place October 11-14, 2022 in Boston, Massachusetts.
Natural Pesticides Marketer Med-X Updates Terms for Proposed $7M IPO
Natural pesticides marketer Med-X (MXRX) has updated terms for a proposed $7M initial public offering.
Med-X Inc. Now Plans to Offer 1.69M Shares in IPO
By Stephen Nakrosis Med-X Inc. on Monday said it expects its initial public offering of 1.69 million shares to price at $4 to $4.20 per share. Previously, the company said it planned to offer 1.56 m
No Data